Crystal structures of human GAR Tfase at low and high pH and with substrate beta-GAR.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biochemistry

• Publication date

  2002-12-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI020522MPMID 12450384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway.

  2002cited by this paper
• Unexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of GAR transformylase.

  2001cited by this paper
• Structures of Prolyl Oligopeptidase Substrate/Inhibitor Complexes

  2001cited by this paper
• Use of TLS parameters to model anisotropic displacements in macromolecular refinement.

  2001cited by this paper
• Design, synthesis, and biological evaluation of fluoronitrophenyl substituted folate analogues as potential inhibitors of GAR transformylase and AICAR transformylase.

  2000cited by this paper
• Molecular structure of Escherichia coli PurT-encoded glycinamide ribonucleotide transformylase.

  2000cited by this paper
• Synthesis and evaluation of aza HUN-7293.

  2000cited by this paper
• Clinical pharmacokinetics of antitumor antifolates.

  1999cited by this paper
• New insights into inhibitor design from the crystal structure and NMR studies of Escherichia coli GAR transformylase in complex with beta-GAR and 10-formyl-5,8,10-trideazafolic acid.

  1999cited by this paper
• Catalytic mechanism of Escherichia coli glycinamide ribonucleotide transformylase probed by site-directed mutagenesis and pH-dependent studies.

  1999cited by this paper
• X-ray crystal structure of aminoimidazole ribonucleotide synthetase (PurM), from the Escherichia coli purine biosynthetic pathway at 2.5 A resolution.

  1999cited by this paper
• A single mutation disrupts the pH-dependent dimerization of glycinamide ribonucleotide transformylase.

  1998cited by this paper
• Evaluation of the kinetic mechanism of Escherichia coli glycinamide ribonucleotide transformylase.

  1998cited by this paper
• The human trifunctional enzyme of de novo purine biosynthesis: heterologous expression, purification, and preliminary characterization.

  1998cited by this paper
• A pH-dependent stabilization of an active site loop observed from low and high pH crystal structures of mutant monomeric glycinamide ribonucleotide transformylase at 1.8 to 1.9 A.

  1998cited by this paper
• Protein structure-based design, synthesis, and biological evaluation of 5-thia-2,6-diamino-4(3H)-oxopyrimidines: potent inhibitors of glycinamide ribonucleotide transformylase with potent cell growth inhibition.

  1997cited by this paper
• The human glycinamide ribonucleotide transformylase domain: purification, characterization, and kinetic mechanism.

  1997cited by this paper
• Phase combination and cross validation in iterated density-modification calculations.

  1996cited by this paper
• Glycinamide ribonucleotide transformylase undergoes pH-dependent dimerization.

  1996cited by this paper
• A rapid screen of active site mutants in glycinamide ribonucleotide transformylase.

  1996cited by this paper
• The Human purH Gene Product, 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase

  1996cited by this paper
• Towards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide ribonucleotide transformylase at 1.96 A resolution.

  1995cited by this paper
• Protein hydration observed by X-ray diffraction. Solvation properties of penicillopepsin and neuraminidase crystal structures.

  1994cited by this paper
• Structures of apo and complexed Escherichia coli glycinamide ribonucleotide transformylase.

  1993cited by this paper
• Crystal structure of glycinamide ribonucleotide transformylase from Escherichia coli at 3.0 A resolution. A target enzyme for chemotherapy.

  1992cited by this paper
• Heterologous expression and purification of active human phosphoribosylglycinamide formyltransferase as a single domain

  1992cited by this paper
• Improved methods for building protein models in electron density maps and the location of errors in these models.

  1991cited by this paper
• Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferase.

  1991cited by this paper
• De novo purine nucleotide biosynthesis: cloning of human and avian cDNAs encoding the trifunctional glycinamide ribonucleotide synthetase-aminoimidazole ribonucleotide synthetase-glycinamide ribonucleotide transformylase by functional complementation in E. coli.

  1990cited by this paper
• Subcloning, characterization, and affinity labeling of Escherichia coli glycinamide ribonucleotide transformylase.

  1990cited by this paper
• Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate.

  1990cited by this paper
• Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate.

  1990cited by this paper
• Active-site mapping and site-specific mutagenesis of glycinamide ribonucleotide transformylase from Escherichia coli.

  1990cited by this paper
• Slow-cooling protocols for crystallographic refinement by simulated annealing.

  1990cited by this paper
• Cloning of three human multifunctional de novo purine biosynthetic genes by functional complementation of yeast mutations.

  1990cited by this paper
• Adenosinergic Modulation of Homocysteine‐Induced Seizures in Mice

  1990cited by this paper
• A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis.

  1989cited by this paper
• Mammalian glycinamide ribonucleotide transformylase. Kinetic mechanism and associated de novo purine biosynthetic activities.

  1989cited by this paper
• Crystal structure of human dihydrofolate reductase complexed with folate.

  1988cited by this paper
• Synthesis and biological properties of 5,10-dideaza-5,6,7,8-tetrahydrofolic acid.

  1988cited by this paper
• Atomic structure of thymidylate synthase: target for rational drug design.

  1987cited by this paper
• alpha-Carboxyl-linked glutamates in the folylpolyglutamates of Escherichia coli.

  1986cited by this paper
• Structural and mechanistic studies on the HeLa and chicken liver proteins that catalyze glycinamide ribonucleotide synthesis and formylation and aminoimidazole ribonucleotide synthesis.

  1986cited by this paper
• In vitro synthesis of alpha-carboxyl-linked folylpolyglutamates by an enzyme preparation from Escherichia coli.

  1986cited by this paper
• Synthesis of the antileukemic agents 5,10-dideazaaminopterin and 5,10-dideaza-5,6,7,8-tetrahydroaminopterin.

  1985cited by this paper
• Polyglutamation of methotrexate. Is methotrexate a prodrug?

  1985cited by this paper
• Mammalian folyl polyglutamate synthetase: partial purification and properties of the mouse liver enzyme.

  1984cited by this paper
• Enzymatic synthesis of polyglutamate derivatives of 7-hydroxymethotrexate.

  1984cited by this paper
• Characterization of the function of mammalian folylpolyglutamate synthetase (FPGS).

  1983cited by this paper
• Regulation of folylpoly-gamma-glutamate synthesis in bacteria: in vivo and in vitro synthesis of pteroylpoly-gamma-glutamates by Lactobacillus casei and Streptococcus faecalis

  1983cited by this paper
• N10-Formyltetrahydrofolate is the formyl donor for glycinamide ribotide transformylase in Escherichia coli.

  1978cited by this paper
• Solvent content of protein crystals.

  1968cited by this paper
• Some crystal forms of bovine chymotrypsinogen B and chymotrypsinogen A.

  1968cited by this paper

• A Fragment-Based Screen for Inhibitors of Escherichia coli N5-CAIR Mutase

  2024cites this paper
• Reversible Photovoltage Generation Using Metastable-State Photoacids in the Solid State with Visible Light

  2021cites this paper
• PvdF of pyoverdin biosynthesis is a structurally unique N10-formyltetrahydrofolate-dependent formyltransferase.

  2019cites this paper
• A recurrent GARS mutation causes distal hereditary motor neuropathy

  2019cites this paper
• Characterization of AICAR transformylase/IMP cyclohydrolase (ATIC) from Staphylococcus lugdunensis

  2017cites this paper
• Characterization of Trifunctional Glycinamide Ribonucleotide Synthetase and its Role in Purinosome Complex

  2014cites this paper
• The purinosome, a multi-protein complex involved in the de novo biosynthesis of purines in humans.

  2013cites this paper
• Structures and reaction mechanisms of the two related enzymes, PurN and PurU.

  2013cites this paper
• Biological and structural evaluation of 10R- and 10S-methylthio-DDACTHF reveals a new role for sulfur in inhibition of glycinamide ribonucleotide transformylase.

  2013cites this paper
• The human proton-coupled folate transporter

  2012cites this paper
• Synthesis of furo[2,3-d]pyrimidines, thieno[2,3- d]pyrimidines, pyrrolo[2,3-d]pyrimidines as classical and nonclassical antifolates, receptor tyrosine kinase (RTK) inhibitors and antimitotic agents

  2012cites this paper
• Expression, crystallization and preliminary X-ray analysis of the phosphoribosylglycinamide formyltransferase from Streptococcus mutans.

  2011influential citation
• Structural studies of tri-functional human GART

  2010cites this paper
• Structural studies of trifunctional human GART

  2010cites this paper
• Structures of glycinamide ribonucleotide transformylase (PurN) from Mycobacterium tuberculosis reveal a novel dimer with relevance to drug discovery.

  2009cites this paper
• Protein preparation, crystallization and preliminary crystallographic studies of Bacillus subtilis glycinamide ribonucleotide transformylase.

  2009cites this paper
• Mutations in the Chinese hamster ovary cell GART gene of de novo purine synthesis.

  2009cites this paper
• Phylogenetic Analysis and in Silico Characterization of the GARS-AIRS-GART Gene which Codes for a tri-Functional Enzyme Protein Involved in de novo Purine Biosynthesis

  2009cites this paper
• New Route to N-Formylation of Primary Amines with Amino Acids as a Source of CO Using Polyaniline Catalyst

  2009cites this paper
• Structural biology of the purine biosynthetic pathway

  2008cites this paper
• The study of helical distortions due to environmental changes: choice of parameters.

  2007cites this paper
• Human glycinamide ribonucleotide transformylase: active site mutants as mechanistic probes.

  2007cites this paper
• Intracellular pH sensors: design principles and functional significance.

  2007cites this paper
• Derivation and Characterization of a Monoclonal Antibody Against Human Glycinamide Ribonucleotide Formyltransferase

  2006cites this paper
• A Mycothiol Synthase Mutant of Mycobacterium smegmatis Produces Novel Thiols and Has an Altered Thiol Redox Status

  2005cites this paper
• The apo and ternary complex structures of a chemotherapeutic target: human glycinamide ribonucleotide transformylase.

  2005cites this paper
• Inhibition of glycinamide ribonucleotide formyltransferase results in selective inhibition of macrophage cytokine secretion in vitro and in vivo efficacy in rat adjuvant arthritis.

  2005cites this paper
• Crystal Structure of Avian Aminoimidazole-4-carboxamide Ribonucleotide Transformylase in Complex with a Novel Non-folate Inhibitor Identified by Virtual Ligand Screening*

  2004cites this paper
• Structural insights into the human and avian IMP cyclohydrolase mechanism via crystal structures with the bound XMP inhibitor.

  2004cites this paper
• Rational design, synthesis, evaluation, and crystal structure of a potent inhibitor of human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid.

  2003cites this paper
• On the structural and functional modularity of glycinamide ribonucleotide formyltransferases

  2003influential citation
• Design, synthesis, and biological evaluation of simplified alpha-keto heterocycle, trifluoromethyl ketone, and formyl substituted folate analogues as potential inhibitors of GAR transformylase and AICAR transformylase.

  2003cites this paper
• Design, synthesis and biological evaluation of 10-CF3CO-DDACTHF analogues and derivatives as inhibitors of GAR Tfase and the de novo purine biosynthetic pathway.

  2003cites this paper
• 10-(2-benzoxazolcarbonyl)-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid: a potential inhibitor of GAR transformylase and AICAR transformylase.

  2003cites this paper